Physician profile
Eric Kim
NPI 1891828687
$9,824.79
in general payments reported to CMS, 2019-2025
10 companies · $3,262 in 2025
The $3,262 reported for 2025 was more than what 93% of Oral & Maxillofacial Surgery providers received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,430 · 2020: $162 · 2021: $2,370 · 2022: $716 · 2023: $569 · 2024: $1,316 · 2025: $3,262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,637 · Travel and Lodging: $1,510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,636.87 |
| Travel and Lodging | $1,509.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $3,546.48 | 2024-2025 | |
| Straumann USA LLC | $3,358.02 | 2019-2023 | |
| Kls-Martin L.P. | $1,619.38 | 2019-2025 | |
| Nobel Biocare USA | $530.55 | 2019-2023 | Nobelactive |
| Depuy Synthes Sales INC. | $178.39 | 2022 | |
| Stryker Corporation | $163.11 | 2021-2023 | Vsp System, Vsp Cranial |
| Orapharma, A Division of Bausch Health US, LLC | $146.48 | 2019-2024 | Ossix Plus |
| Geistlich Pharma, North America, INC. | $139.42 | 2019-2025 | Biomaterials, Geistlich Bio-Gide |
| Acelrx Pharmaceuticals, INC. | $125.00 | 2019 | |
| Ethicon US, LLC | $17.96 | 2024 | Harmonic, Surgicel Nu-Knit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.